Cell therapy landscape in India: Current advances, opportunities, challenges, and future directions

Cell and immunotherapy products are known for targeting the root cause of health ailments and potentially curing cancers and other degenerative indications. The rapid growth in cell therapy products, CRISPR-based gene editing, and stem cell applications in India is changing the face of personalized medicine, putting the country at the forefront of innovative product development. The therapy develops through strong regulatory guidelines and collaborative efforts among academia, industry, and government. However, high costs, less infrastructure, regulatory complexity, and ethics are hurdles in implementing the idea. This review emphasizes the progress made in cell therapy research in India and discusses the challenges as well as the possible strategies for overcoming them.

Authors

Institutions

Publication Details

Journal
Chemical Biology Letters
Published
2025-03-14
DOI
https://doi.org/10.62110/sciencein.cbl.2025.v12.1270
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cell therapy landscape in India: Current advances, opportunities, challenges, and future directions

Shailender Gugalavath, Ashis Banerjee, Deepak Singh, Shubham Verma et al.
Chemical Biology Letters
CAR-T cell therapy research
article

Cell therapy landscape in India: Current advances, opportunities, challenges, and future directions

Shailender Gugalavath, Ashis Banerjee, Deepak Singh, Shubham Verma, Pratik Saha, Tannistha Hota
article en

Abstract

Cell and immunotherapy products are known for targeting the root cause of health ailments and potentially curing cancers and other degenerative indications. The rapid growth in cell therapy products, CRISPR-based gene editing, and stem cell applications in India is changing the face of personalized medicine, putting the country at the forefront of innovative product development. The therapy develops through strong regulatory guidelines and collaborative efforts among academia, industry, and government. However, high costs, less infrastructure, regulatory complexity, and ethics are hurdles in implementing the idea. This review emphasizes the progress made in cell therapy research in India and discusses the challenges as well as the possible strategies for overcoming them.

Chemical Biology LettersVol. 12(3)
University of Hyderabad (IN), Io Therapeutics (United States) (US), Laboratoire Procédés, Matériaux et Energie Solaire (FR)
Openalex Percentile: Top 68%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.